• Home
  • Biopharmaceutical Research Services
  • Multi-Omics Services
  • Support
  • /assets/images/icon/icon-email-2.png

    Email:

    info@MtoZ-Biolabs.com

    Antibody Amino Acid Sequence

      The antibody amino acid sequence represents the linear order of amino acids that constitute the antibody protein and serves as the fundamental blueprint for determining both its structural architecture and functional properties. Antibodies, or immunoglobulins, are highly specific proteins secreted by B cells that recognize and bind to antigens, exerting a range of immune defense activities such as neutralization, opsonization, and immune system activation. This sequence not only governs antigen recognition but also impacts the antibody's stability, pharmacokinetics, binding affinity, and effector mechanisms. In various domains—including therapeutic antibody development, vaccine evaluation, monoclonal antibody screening, affinity maturation, and antibody engineering—obtaining and analyzing the antibody amino acid sequence is a critical step. A thorough understanding of its composition and functional implications is thus essential for both fundamental immunology and biopharmaceutical innovation.

       

      The antibody amino acid sequence comprises two primary structural regions: the variable region and the constant region. The variable region, which confers antigen specificity, is composed of the variable (V) domains of both the heavy and light chains. Within these regions lie the complementarity-determining regions (CDRs)—three hypervariable loops that form the principal binding interface with the antigen. Among them, CDR3 is the most diverse and plays a pivotal role in shaping the specificity and chemical characteristics of the antigen-binding site. This diversity is generated through mechanisms such as V(D)J gene recombination, somatic hypermutation, and clonal selection during B cell development, giving rise to an extraordinarily diverse antibody repertoire. In contrast, the constant region of the antibody amino acid sequence is relatively conserved and determines isotype classification (e.g., IgG, IgA, IgM), effector functions, and interactions with immune components such as Fc receptors and complement proteins. Isotype-specific constant region sequences influence tissue distribution, effector activity (e.g., ADCC, CDC), and serum half-life. Therefore, therapeutic antibody design must consider both variable region optimization for target binding and constant region selection for functional tuning.

       

      Antibody amino acid sequences are typically obtained through genomic and proteomic approaches. Classical strategies involve isolating RNA from B cells, amplifying variable region genes via RT-PCR, and sequencing via Sanger or next-generation sequencing (NGS), followed by in silico translation into amino acid sequences. However, these approaches capture gene expression profiles and may not fully represent post-translational modifications or splicing variants. To address these limitations, mass spectrometry-based proteomic sequencing has emerged as a valuable complement, particularly in cases involving unknown antibodies or limited access to B cell samples. This technique enables direct determination of amino acid sequences from purified antibody proteins, providing crucial data for structural modeling and functional validation.

       

      Comprehensive analysis of antibody amino acid sequences extends beyond acquisition and includes sequence alignment, CDR annotation, affinity prediction, homology modeling, and immunogenicity assessment. Bioinformatics tools such as IgBLAST and IMGT are commonly used to classify variable regions, identify mutation hotspots, and trace antibody lineage. Computational modeling further facilitates the prediction of antibody-antigen binding conformations, guiding affinity maturation and humanization efforts.

       

      MtoZ Biolabs is dedicated to delivering high-quality analytical and sequence interpretation services. With deep domain expertise and robust data processing capabilities, MtoZ Biolabs empowers efficient and accurate antibody sequence research to advance innovation in biotherapeutics.

       

      MtoZ Biolabs, an integrated chromatography and mass spectrometry (MS) services provider.

      Related Services

    Submit Inquiry
    Name *
    Email Address *
    Phone Number
    Inquiry Project
    Project Description *

     

    How to order?


    /assets/images/icon/icon-message.png

    Submit Inquiry

    /assets/images/icon/icon-return.png